(3DPrint.com PRO is available only to subscribers)
When the U.S. Food and Drug Administration (FDA) approved the world’s first 3D printed pill in 2015, it marked a turning point in pharmaceutical manufacturing. The drug was Spritam, a fast-dissolving epilepsy medication made by Aprecia Pharmaceuticals using its binder-jetting ZipDose technology. Nearly a decade later, the idea of 3D printed pills is no longer experimental. The technology is taking shape, even if it’s still far from mainstream.
While the field remains small, many startups and pharmaceutical giants are now using 3D printing to reshape how drugs are formulated, delivered, and distributed. From personalized polypills and chewable tablets to drug-loaded implants and microneedle patches, the possibilities are expanding — and so is investor interest.
Already a subscriber?
You are set to receive premium content directly to your inbox twice a month.
